Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Apr-24 9:00 PM View:  | Pulik Richard CFO | Roivant Sciences Ltd. (ROIV) | 28-Apr-24 | Payment of Exercise | 2,340 | $11.03 | $25,810.20 | (< 1%) 297.38K to 295.04K | |
| 26-Apr-24 9:01 PM View: | Epperly Melissa B, Director | Roivant Sciences Ltd. (ROIV) | 24-Apr-24 | Grant | 1,146 | -- | -- | 5% 21.54K to 22.68K | |
| 26-Apr-24 9:01 PM View: | Momtazee James C Director | Roivant Sciences Ltd. (ROIV) | 24-Apr-24 | Payment of Exercise | 293 | $10.90 | $3,193.70 | (< 1%) 77.83K to 77.54K | |
| 26-Apr-24 9:01 PM View: | Fitzgerald Meghan Director | Roivant Sciences Ltd. (ROIV) | 24-Apr-24 | Payment of Exercise | 83 | $10.90 | $904.70 | (< 1%) 13.95K to 13.86K | |
| 26-Apr-24 9:01 PM View: | Oren Ilan Director | Roivant Sciences Ltd. (ROIV) | 24-Apr-24 | Payment of Exercise | 54 | $10.90 | $588.60 | (< 1%) 80.46K to 80.41K | |
| 26-Apr-24 9:01 PM View: | Epperly Melissa B, Director | Roivant Sciences Ltd. (ROIV) | 24-Apr-24 | Payment of Exercise | 123 | $10.90 | $1,340.70 | (< 1%) 22.68K to 22.56K | |
| 26-Apr-24 9:01 PM View: | Momtazee James C Director | Roivant Sciences Ltd. (ROIV) | 24-Apr-24 | Grant | 1,490 | -- | -- | 2% 76.34K to 77.83K | |
| 26-Apr-24 9:01 PM View: | Fitzgerald Meghan Director | Roivant Sciences Ltd. (ROIV) | 24-Apr-24 | Grant | 1,261 | -- | -- | 10% 12.69K to 13.95K | |
| 26-Apr-24 9:01 PM View: | Oren Ilan Director | Roivant Sciences Ltd. (ROIV) | 24-Apr-24 | Grant | 2,121 | -- | -- | 3% 78.34K to 80.46K | |
| 24-Apr-24 9:12 PM View: | Kumar Rakhi Chief Accounting Officer | Roivant Sciences Ltd. (ROIV) | 22-Apr-24 | Grant | 38,685 | -- | -- | (15%) 255.26K to 216.57K | |
| 24-Apr-24 9:12 PM View: | Pulik Richard CFO | Roivant Sciences Ltd. (ROIV) | 22-Apr-24 | Grant | 38,685 | -- | -- | 15% 258.7K to 297.38K | |
| 23-Apr-24 9:00 PM View: | Kumar Rakhi Chief Accounting Officer | Roivant Sciences Ltd. (ROIV) | 20-Apr-24 | Payment of Exercise | 9,881 | $10.46 | $103,355.00 | (5%) 187.77K to 177.89K | |
| 23-Apr-24 9:01 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 20-Apr-24 | Payment of Exercise | 10,945 | $10.46 | $114,485.00 | (< 1%) 1.16M to 1.15M | |
| 23-Apr-24 9:01 PM View: | Pulik Richard CFO | Roivant Sciences Ltd. (ROIV) | 20-Apr-24 | Payment of Exercise | 8,515 | $10.46 | $89,066.90 | (3%) 267.21K to 258.7K | |
| 23-Apr-24 9:00 PM View: | Venker Eric President & COO | Roivant Sciences Ltd. (ROIV) | 20-Apr-24 | Payment of Exercise | 16,002 | $10.46 | $167,381.00 | (3%) 500.2K to 484.2K | |
| 02-Apr-24 9:00 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 30-Mar-24 | Payment of Exercise | 215,991 | $10.54 | $2,276,550.00 | (16%) 1.38M to 1.16M | |
| 02-Apr-24 9:00 PM View: | Sukhatme Mayukh Pres&Chief Investment Officer Director | Roivant Sciences Ltd. (ROIV) | 30-Mar-24 | Payment of Exercise | 366,211 | $10.54 | $3,859,860.00 | (6%) 5.68M to 5.31M | |
| 02-Apr-24 9:00 PM View: | Sukhatme Mayukh Pres&Chief Investment Officer Director | Roivant Sciences Ltd. (ROIV) | 30-Mar-24 | Option Exercise | 729,081 | -- | -- | 15% 4.95M to 5.68M | |
| 02-Apr-24 9:00 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 30-Mar-24 | Option Exercise | 390,579 | -- | -- | 39% 990.06K to 1.38M | |
| 02-Apr-24 9:00 PM View: | Pulik Richard CFO | Roivant Sciences Ltd. (ROIV) | 28-Mar-24 | Payment of Exercise | 2,341 | $10.54 | $24,674.10 | (< 1%) 269.55K to 267.21K | |
| 22-Mar-24 9:00 PM View: | Kumar Rakhi Chief Accounting Officer | Roivant Sciences Ltd. (ROIV) | 20-Mar-24 | Payment of Exercise | 1,506 | $10.01 | $15,075.10 | (< 1%) 189.28K to 187.77K | |
| 22-Mar-24 9:00 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 20-Mar-24 | Payment of Exercise | 10,945 | $10.01 | $109,559.00 | (1%) 1.0M to 990.06K | |
| 22-Mar-24 9:00 PM View: | Venker Eric President & COO | Roivant Sciences Ltd. (ROIV) | 20-Mar-24 | Payment of Exercise | 16,003 | $10.01 | $160,190.00 | (3%) 516.21K to 500.2K | |
| 07-Mar-24 6:35 PM View: | Manchester Keith S Director | Roivant Sciences Ltd. (ROIV) | 07-Mar-24 | Disposition (other) | 30,257,700 | -- | -- | (38%) 79.37M to 49.12M | |
| 07-Mar-24 6:09 PM View: | Gold Daniel Allen Director | Roivant Sciences Ltd. (ROIV) | 07-Mar-24 | Disposition (other) | 45,821,800 | -- | -- | (37%) 122.47M to 76.65M | |
| 07-Mar-24 5:53 PM View: | Qvt Financial Lp 10% Owner | Roivant Sciences Ltd. (ROIV) | 07-Mar-24 | Disposition (other) | 45,821,800 | -- | -- | (41%) 112.54M to 66.72M | |
| 01-Mar-24 9:00 PM View: | Pulik Richard CFO | Roivant Sciences Ltd. (ROIV) | 28-Feb-24 | Payment of Exercise | 1,630 | $11.71 | $19,087.30 | (< 1%) 271.18K to 269.55K | |
| 22-Feb-24 9:01 PM View: | Kumar Rakhi Chief Accounting Officer | Roivant Sciences Ltd. (ROIV) | 20-Feb-24 | Payment of Exercise | 1,508 | $11.54 | $17,402.30 | (< 1%) 190.78K to 189.28K | |
| 22-Feb-24 9:01 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 20-Feb-24 | Payment of Exercise | 10,945 | $11.54 | $126,305.00 | (1%) 1.01M to 1.0M | |
| 22-Feb-24 9:01 PM View: | Venker Eric President & COO | Roivant Sciences Ltd. (ROIV) | 20-Feb-24 | Payment of Exercise | 16,002 | $11.54 | $184,663.00 | (3%) 532.21K to 516.21K | |
| 09-Feb-24 9:00 PM View: | Venker Eric President & COO | Roivant Sciences Ltd. (ROIV) | 09-Feb-24 | Option Exercise | 96,950 | $3.85 | $373,258.00 | 18% 532.21K to 629.16K | |
| 09-Feb-24 9:00 PM View: | Venker Eric President & COO | Roivant Sciences Ltd. (ROIV) | 09-Feb-24 | Option Sale | 96,950 | $10.92 | $1,058,690.00 | (15%) 629.16K to 532.21K | |
| 30-Jan-24 9:00 PM View: | Pulik Richard CFO | Roivant Sciences Ltd. (ROIV) | 28-Jan-24 | Payment of Exercise | 1,896 | $10.37 | $19,661.50 | (< 1%) 273.08K to 271.18K | |
| 23-Jan-24 9:00 PM View: | Kumar Rakhi Chief Accounting Officer | Roivant Sciences Ltd. (ROIV) | 20-Jan-24 | Payment of Exercise | 1,506 | $10.35 | $15,587.10 | (< 1%) 192.29K to 190.78K | |
| 23-Jan-24 9:00 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 20-Jan-24 | Payment of Exercise | 10,945 | $10.35 | $113,281.00 | (1%) 1.02M to 1.01M | |
| 23-Jan-24 9:00 PM View: | Venker Eric President & COO | Roivant Sciences Ltd. (ROIV) | 20-Jan-24 | Payment of Exercise | 12,377 | $10.35 | $128,102.00 | (2%) 544.58K to 532.21K | |
| 23-Jan-24 9:00 PM View: | Momtazee James C Director | Roivant Sciences Ltd. (ROIV) | 19-Jan-24 | Grant | 1,570 | -- | -- | 2% 74.77K to 76.34K | |
| 23-Jan-24 9:00 PM View: | Fitzgerald Meghan Director | Roivant Sciences Ltd. (ROIV) | 19-Jan-24 | Grant | 1,328 | -- | -- | 12% 11.36K to 12.69K | |
| 23-Jan-24 9:00 PM View: | Oren Ilan Director | Roivant Sciences Ltd. (ROIV) | 19-Jan-24 | Grant | 3,366 | -- | -- | 4% 74.98K to 78.34K | |
| 23-Jan-24 9:00 PM View: | Epperly Melissa B, Director | Roivant Sciences Ltd. (ROIV) | 19-Jan-24 | Grant | 1,207 | -- | -- | 6% 20.33K to 21.54K | |
| 03-Jan-24 4:56 PM View: | Ramaswamy Vivek 10% Owner | Roivant Sciences Ltd. (ROIV) | 02-Jan-24 | Private Sale | 3,000,000 | $11.05 | $33,150,000.00 | (5%) 54.93M to 51.93M | |
| 29-Dec-23 9:00 PM View: | Pulik Richard CFO | Roivant Sciences Ltd. (ROIV) | 28-Dec-23 | Payment of Exercise | 1,913 | $11.37 | $21,750.80 | (< 1%) 274.99K to 273.08K | |
| 29-Dec-23 9:00 PM View: | Ramaswamy Vivek 10% Owner | Roivant Sciences Ltd. (ROIV) | 27-Dec-23 | Payment of Exercise | 133,911 | $11.58 | $1,550,690.00 | (< 1%) 55.06M to 54.93M | |
| 29-Dec-23 9:00 PM View: | Ramaswamy Vivek 10% Owner | Roivant Sciences Ltd. (ROIV) | 27-Dec-23 | Option Exercise | 275,227 | -- | -- | < 1% 54.79M to 55.06M | |
| 29-Dec-23 9:00 PM View: | Sukhatme Mayukh Pres&Chief Investment Officer | Roivant Sciences Ltd. (ROIV) | 27-Dec-23 | Option Exercise | 71,365 | -- | -- | 1% 4.88M to 4.95M | |
| 29-Dec-23 9:00 PM View: | Kumar Rakhi Chief Accounting Officer | Roivant Sciences Ltd. (ROIV) | 27-Dec-23 | Payment of Exercise | 6 | $11.58 | $69.48 | (< 1%) 192.29K to 192.29K | |
| 29-Dec-23 9:00 PM View: | Kumar Rakhi Chief Accounting Officer | Roivant Sciences Ltd. (ROIV) | 27-Dec-23 | Option Exercise | 13 | -- | -- | < 1% 192.28K to 192.29K | |
| 29-Dec-23 9:00 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 27-Dec-23 | Payment of Exercise | 22,043 | $11.58 | $255,258.00 | (2%) 1.04M to 1.02M | |
| 29-Dec-23 9:00 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 27-Dec-23 | Option Exercise | 38,453 | -- | -- | 4% 1.01M to 1.04M | |
| 22-Dec-23 7:00 PM View: | Venker Eric President & COO | Roivant Sciences Ltd. (ROIV) | 20-Dec-23 | Payment of Exercise | 16,003 | $9.96 | $159,390.00 | (3%) 560.59K to 544.58K |
